OTC: ABPO

Abpro Holdings, Inc.

Healthcare | Biotechnology

$0.21

Volume5.4K

Abpro Holdings, Inc. (OTC: ABPO) is a biotechnology company trading at $0.21. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:45 UTC.

What Abpro Holdings, Inc. does

Abpro Holdings, Inc. is a clinical-stage biotechnology company that develops therapeutic antibodies using its DiversImmune and MultiMab antibody platforms. The company's pipeline includes product candidates such as ABP-102 and ABP-201, which are in early development stages and have not yet been tested in human subjects. Through its AbMed subsidiary, the company has in-licensed intellectual property related to ABP-201 from MedImmune (now AstraZeneca), though this program is currently paused at the IND-enabling study stage.

Summarized from Abpro Holdings, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Quote
Price	$0.21
Volume	5.4K shares

Revenue Trend

Annual Revenue · Open in Platform →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity

Source: SEC EDGAR · Filed 2025-08-07

Most recent filed transactions — August 2025:

2025-08-07DirectorAward60,600—
2025-08-04CEO and ChairmanPurchase72,035$20.2K
2025-07-29DirectorAward60,600—

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2025-Q4

Yorkville Advisors Global, LP858,333$192.3KNEW
VANGUARD GROUP INC20,084$85.0K-96.8%
GOLDMAN SACHS GROUP INC12,383$52.4K-93.1%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2026-09-01Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2026-08-25Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2026-01-23Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersByung-Hak YoonAuthoritativeSEC 8-K →

Company news

View all →

No qualifying company news in the archive. Full tape in the platform →

Questions this page answers

What does Abpro Holdings, Inc. do?

Abpro Holdings, Inc. is a biotechnology company, listed on OTC as ABPO.

What is ABPO's valuation?

ABPO trades at $0.21, as of 2026-10-11.

When did ABPO last file with the SEC?

Abpro Holdings, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-04. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:45 UTC. This page is also available as JSON at /api/data?ticker=ABPO and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ABPO and 5,000+ tickers.

Create a free account — keep ABPO

For your agent

GET /api/data?ticker=ABPO

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt